A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Biogen Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 68,487 shares of BIIB stock, worth $11.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
68,487
Previous 61,544 11.28%
Holding current value
$11.9 Million
Previous $13.3 Million 19.64%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $1.32 Million - $1.64 Million
6,943 Added 11.28%
68,487 $15.9 Million
Q1 2024

May 09, 2024

SELL
$212.02 - $267.71 $473,652 - $598,064
-2,234 Reduced 3.5%
61,544 $13.3 Million
Q4 2023

Mar 05, 2024

SELL
$222.59 - $267.94 $27,823 - $33,492
-125 Reduced 0.2%
63,778 $16.5 Million
Q4 2023

Feb 06, 2024

SELL
$222.59 - $267.94 $11.1 Million - $13.4 Million
-49,896 Reduced 43.85%
63,903 $16.5 Million
Q3 2023

Nov 13, 2023

SELL
$253.3 - $285.89 $4.18 Million - $4.72 Million
-16,518 Reduced 12.68%
113,799 $29.2 Million
Q2 2023

Dec 12, 2023

BUY
$275.25 - $318.06 $4.55 Million - $5.25 Million
16,518 Added 14.52%
130,317 $37.1 Million
Q2 2023

Aug 08, 2023

SELL
$275.25 - $318.06 $869,514 - $1 Million
-3,159 Reduced 2.37%
130,317 $37.1 Million
Q1 2023

Dec 12, 2023

BUY
$256.56 - $292.34 $4.88 Million - $5.56 Million
19,018 Added 16.71%
132,817 $36.9 Million
Q1 2023

May 01, 2023

BUY
$256.56 - $292.34 $251,685 - $286,785
981 Added 0.74%
133,476 $37.1 Million
Q4 2022

Feb 03, 2023

BUY
$252.44 - $306.72 $513,462 - $623,868
2,034 Added 1.56%
132,495 $36.7 Million
Q3 2022

Nov 08, 2022

SELL
$194.69 - $268.46 $464,725 - $640,814
-2,387 Reduced 1.8%
130,461 $34.8 Million
Q2 2022

Aug 09, 2022

BUY
$187.54 - $223.02 $94,520 - $112,402
504 Added 0.38%
132,848 $27.1 Million
Q1 2022

May 05, 2022

BUY
$193.77 - $244.14 $60,068 - $75,683
310 Added 0.23%
132,344 $27.9 Million
Q4 2021

Feb 02, 2022

BUY
$223.92 - $287.77 $5.27 Million - $6.78 Million
23,545 Added 21.7%
132,034 $31.7 Million
Q3 2021

Oct 26, 2021

BUY
$282.99 - $369.05 $966,127 - $1.26 Million
3,414 Added 3.25%
108,489 $30.7 Million
Q2 2021

Jul 27, 2021

BUY
$259.0 - $414.71 $1.68 Million - $2.69 Million
6,497 Added 6.59%
105,075 $36.4 Million
Q1 2021

Apr 27, 2021

SELL
$242.95 - $284.63 $1,457 - $1,707
-6 Reduced 0.01%
98,578 $27.6 Million
Q4 2020

Jan 29, 2021

BUY
$236.26 - $355.63 $1.1 Million - $1.65 Million
4,648 Added 4.95%
98,584 $24.1 Million
Q3 2020

Nov 10, 2020

BUY
$264.77 - $305.71 $272,977 - $315,187
1,031 Added 1.11%
93,936 $26.6 Million
Q2 2020

Aug 07, 2020

SELL
$258.66 - $342.55 $186,235 - $246,636
-720 Reduced 0.77%
92,905 $24.9 Million
Q1 2020

Apr 28, 2020

BUY
$268.85 - $341.04 $765,684 - $971,281
2,848 Added 3.14%
93,625 $29.6 Million
Q4 2019

Feb 12, 2020

SELL
$220.06 - $304.07 $7.31 Million - $10.1 Million
-33,205 Reduced 26.78%
90,777 $26.9 Million
Q3 2019

Oct 29, 2019

BUY
$217.44 - $243.88 $872,369 - $978,446
4,012 Added 3.34%
123,982 $28.9 Million
Q2 2019

Jul 30, 2019

SELL
$219.29 - $241.72 $3.49 Million - $3.84 Million
-15,901 Reduced 11.7%
119,970 $28.1 Million
Q1 2019

Apr 22, 2019

SELL
$216.71 - $338.96 $450,973 - $705,375
-2,081 Reduced 1.51%
135,871 $32.1 Million
Q4 2018

Jan 25, 2019

BUY
$278.5 - $352.75 $2.16 Million - $2.74 Million
7,771 Added 5.97%
137,952 $41.5 Million
Q3 2018

Oct 24, 2018

BUY
$293.51 - $383.83 $606,978 - $793,760
2,068 Added 1.61%
130,181 $46 Million
Q2 2018

Jul 09, 2018

BUY
$257.52 - $306.91 $1.21 Million - $1.44 Million
4,704 Added 3.81%
128,113 $37.2 Million
Q1 2018

May 11, 2018

SELL
$260.13 - $367.91 $7.19 Million - $10.2 Million
-27,644 Reduced 18.3%
123,409 $33.8 Million
Q1 2018

Apr 19, 2018

BUY
$260.13 - $367.91 $13.5 Million - $19 Million
51,773 Added 52.15%
151,053 $41.4 Million
Q4 2017

Jan 24, 2018

SELL
$307.64 - $344.58 $2.64 Million - $2.96 Million
-8,584 Reduced 7.96%
99,280 $31.6 Million
Q3 2017

Oct 17, 2017

BUY
$281.15 - $329.69 $30.3 Million - $35.6 Million
107,864
107,864 $33.8 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.